Ikang Healthcare ADR (KANG) 18.22 $KANG iKang A
Post# of 273257
Posted On: 09/03/2016 11:13:17 PM
Ikang Healthcare ADR (KANG) 18.22 $KANG
iKang Announces Unaudited Financial Results for the First Quarter Ended June 30, 2016
GlobeNewswire - Wed Aug 31, 4:00PM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"
(Nasdaq:KANG), the largest provider in China's fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in calendar year 2014, today announced its unaudited financial results for the first quarter ended June 30, 2016.
KANG: 18.22 (unch)
iKang Schedules 2016 Unaudited First Quarter Earnings Release on August 31, 2016
GlobeNewswire - Mon Aug 22, 6:00AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company" (Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that it will release its unaudited financial results for the first quarter ended June 30, 2016 on August 31, 2016 after the US market closes.
KANG: 18.22 (unch)
iKang Filed 2015 Annual Report on Form 20-F
GlobeNewswire - Mon Aug 01, 6:45AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company" (Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that it filed its annual report on Form 20-F for the fiscal year ended March 31, 2016 with the U.S. Securities and Exchange Commission (the "SEC" on July 29, 2016. The annual report on Form 20-F, which contains the Company's audited financial statements, can be accessed on the SEC's website at http://www.sec.gov as well as via the Company's investor relations website at http://ir.ikang.com. Hard copies of the annual report are available, free of charge, to shareholders upon request.
KANG: 18.22 (unch)
iKang Announces Further Update on Potential "Going Private" Transaction
GlobeNewswire - Thu Jun 09, 8:25AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company" (Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced a further update on the potential going private transaction proposed, respectively, by certain buyer groups, including (i) Mr. Ligang Zhang ("Mr. Zhang" , Founder, Chairman and Chief Executive Officer of iKang, and certain of Mr. Zhang's affiliated entities, and FV Investment Holdings (together with certain other investors, the "Founder Buyer Group" , (ii) Meinian Onehealth Healthcare Group Co. (formerly known as Jiangsu Sanyou Group Co., Ltd.) ("Meinian" , Cathay Capital Private Equity SAS ("Cathay" , Shenzhen Ping An Decheng Investment Co., Ltd. ("Ping An" , Taiping Guofa (Suzhou) Capital Management Co., Ltd. ("Taiping" , Sequoia China Investment Management LLP ("Sequoia" and Huatai Ruilian Fund Management Co., Ltd. ("Huatai Ruilian," and together with Meinian, Cathay, Ping An, Taiping, Sequoia and certain other investors, the "Meinian Buyer Group" and (iii) Yunfeng Capital.
KANG: 18.22 (unch)
iKang Announces Receipt of Competing Non-Binding "Going Private" Proposal
GlobeNewswire - Mon Jun 06, 8:46AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company" (Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that its board of directors (the "Board" received a preliminary non-binding proposal letter, dated June 6, 2016, from Yunfeng Capital, proposing a going-private transaction in which Yunfeng Capital would acquire all of the outstanding Class A common shares ("Class A Shares" , Class C common shares ("Class C Shares," and together with Class A Shares, the "Shares" and American depositary shares ("ADSs," each representing 1/2 of a Class A Share) of the Company in an all-cash transaction for US$20.00 to US$25.00 per ADS or US$40.00 to US$50.00 per Share (the "Yunfeng Capital Proposal" .
KANG: 18.22 (unch)
Why These Stocks are Under the Investor Community's Microscope? - Bruker, Quintiles Transnational Holdings, iKang Healthcare Group, and TrovaGene
PR Newswire - Wed Jun 01, 7:20AM CDT
In today's pre-market research, ActiveWallSt.com has selected the following Medical Laboratories and Research stocks for your evaluation: Bruker Corp. (NASDAQ: BRKR), Quintiles Transnational Holdings Inc. (NYSE: Q), iKang Healthcare Group Inc. (NASDAQ: KANG), and TrovaGene Inc. (NASDAQ: TROV). Access these equities free technical alerts at:
Q: 76.96 (-0.46), TROV: 4.96 (unch), KANG: 18.22 (unch), BRKR: 22.38 (-0.06)
iKang Sues Meinian Onehealth Healthcare Over IP Infringement
GlobeNewswire - Tue May 24, 8:50AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company" (Nasdaq:KANG), China's largest private preventive healthcare services provider, reported that, on April 28, 2016, the Company filed a complaint (the "Copyright Claim" with the Shanghai Intellectual Property Court against Shanghai Mei Dong Software Development Co., Ltd. ("Shanghai Mei Dong" , WANG Haifeng, Deputy General Manager of Shanghai Mei Dong, Meinian Onehealth Healthcare (Group) Co., Ltd. ("Meinian Onehealth" , and Shanghai Sheng Jia Clinic Co., Ltd. ("Sheng Jia" as they have jointly infringed the Company's copyright of medical examination software systems (the "Infringed Softwares" . The Company has requested Meinian Onehealth and Sheng Jia to delete and stop using the relevant softwares (the "Infringing Softwares" , mitigate the impacts, apologize publicly for their violations, and repay the financial damages they have caused in the amount of RMB 53 million. The Shanghai Intellectual Property Court has accepted the Company's complaint (Case number: (2016) Hu73 Min Chu 339-342).
KANG: 18.22 (unch)
iKang Announces Acquisition of Two Medical Centers in Beijing
GlobeNewswire - Fri May 20, 6:00AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company" (Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that it has completed the acquisition of 100% equity interest in Beijing Bohui Clinic Co. Ltd. ("Beijing Bohui" and Beijing Zhongpu Bohui Clinic Co. Ltd. ("Zhongpu Bohui" . Beijing Bohui has now officially opened after its relocation, acquiring all necessary licenses including the Medical Institutions Practice License and Business License, and Zhongpu Bohui is currently in the middle of evaluating a new location for its business.
KANG: 18.22 (unch)
Expanded Meinian Consortium Reiterates Its Commitment to Acquiring iKang by Further Improving Offer
PR Newswire - Wed Jan 06, 10:48AM CST
Jiangsu Sanyou Group Co Ltd (SZSE: 002044) today announces that it has updated its business license to change the company name to Meinian Onehealth Healthcare Holding Co., Ltd and that the consortium of which it is a member ("the Consortium" or "We" has submitted a further revised and improved proposal (the "Improved Proposal" to acquire iKang Healthcare Group, Inc. (NASDAQ: KANG, "iKang" . The Improved Proposal was submitted to iKang's Special Committee of the Board of Directors (the "Special Committee" and details the transaction structure as well as the Consortium's ability to swiftly complete the transaction. At the same time, the Consortium admitted three new members, Shanghai YuanXing YinShi Equity Investment Limited Partnership (GGV Capital), Shanghai Sailing Capital Management Co., Ltd., and Haitong Auspicate Capital Management Co., Ltd.
KANG: 18.22 (unch)
iKang Announces Acquisition of Shaanxi INLUNG Health Management
GlobeNewswire - Tue Dec 22, 8:03AM CST
iKang Healthcare Group, Inc. ("iKang" or the "Company" (Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that it has acquired 70% equity interest of Xi'an iKang Health Management, which has 100% ownership in three medical centers under the brand name of Xi'an INLUNG, namely Xi'an Lianhu INLUNG Medical Center, Xi'an Weiyang INLUNG Medical Center and Xi'an Yanta INLUNG Medical Center.
KANG: 18.22 (unch)
Meinian Consortium Announces Improved Proposal for iKang
PR Newswire - Mon Dec 14, 12:24PM CST
Jiangsu Sanyou Group Co Ltd (SZSE: 002044, "Jiangsu Sanyou", also known as Meinian Onehealth Healthcare (Group) Co., Ltd) today announces that the consortium of which it is a member ("the Consortium" or "We" has submitted a revised and improved proposal (the "Improved Proposal" to acquire iKang Healthcare Group, Inc. (NASDAQ: KANG, "iKang" . The Improved Proposal was submitted to the Special Committee of the Board of Directors (the "Special Committee" and the Consortium wishes to express that it remains committed to its objective of acquiring iKang.
KANG: 18.22 (unch)
Meinian Responds to iKang's "Poison Pill" Rights Plan
PR Newswire - Thu Dec 03, 12:26PM CST
Jiangsu Sanyou Group Co Ltd (SZSE: 002044, "Jiangsu Sanyou", also known as Meinian Onehealth Healthcare (Group) Co., Ltd, "Meinian" on behalf of the consortium of which it is a member ("the Consortium" acknowledges iKang Healthcare Group, Inc.'s (NASDAQ: KANG, "iKang" announcement of a Rights Agreement (the "Rights Plan", commonly known as a "poison pill" .
KANG: 18.22 (unch)
iKang Healthcare Group, Inc. Adopts Rights Agreement
GlobeNewswire - Wed Dec 02, 8:15AM CST
The Board of Directors of iKang Healthcare Group, Inc. (the "Company" today adopted a Rights Agreement and authorized the issuance of one Right for each outstanding Class A Common Share and Class C Common Share (the "Rights Plan" . After careful consideration, the Board of Directors of the Company (the "Board" deemed it appropriate and prudent to adopt the Rights Plan at this time in order to ensure that all shareholders of the Company receive fair and equal treatment in the event that an unsolicited attempt is made to acquire the Company outside of the process led by the special committee of independent directors of the Company (the "Special Committee" , which was formed to consider the possibility of a "going private" transaction involving the Company.
KANG: 18.22 (unch)
Company News for December 01, 2015
Zacks Equity Research - Zacks Investment Research - Tue Dec 01, 9:10AM CST
Companies in the News are: TGT,KANG,OHGI,SPCB
KANG: 18.22 (unch), TGT: 70.81 (+0.23), SPCB: 3.40 (+0.10), OHGI: 0.70 (-0.02)
iKang Announces Unaudited Financial Results for Fiscal Second Quarter Ended September 30, 2015
GlobeNewswire - Mon Nov 30, 3:00PM CST
iKang Healthcare Group, Inc. ("iKang" or the "Company" (Nasdaq:KANG), the largest provider in China's fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in calendar year 2014, today announced its unaudited financial results for the fiscal second quarter ended September 30, 2015.
KANG: 18.22 (unch)
Consortium Submits Preliminary Non-binding Proposal to Acquire Nasdaq-listed iKang
PR Newswire - Sun Nov 29, 3:15AM CST
Jiangsu Sanyou Group Co Ltd (SZSE: 002044, "Jiangsu Sanyou", also known as Meinian Onehealth Healthcare (Group) Co., Ltd.), announces today that it is a member of a consortium which has submitted a preliminary non-binding proposal (the "Proposal" to acquire iKang Healthcare Group, Inc. ("iKang" (NASDAQ: KANG).
KANG: 18.22 (unch)
iKang Special Committee Engages Financial Advisor and Legal Counsel
GlobeNewswire - Tue Nov 10, 6:00AM CST
iKang Healthcare Group, Inc. ("iKang" or the "Company" (Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that the special committee (the "Special Committee" of the Company's board of directors (the "Board" has retained J.P. Morgan Securities (Asia Pacific) Limited as its financial advisor, Simpson Thacher & Bartlett as its international legal counsel, and Walkers as its Cayman Islands legal counsel in connection with its review and evaluation of the preliminary non-binding proposal letter dated August 31, 2015 from Mr. Ligang Zhang ("Mr. Zhang" , the Company's founder, chairman and chief executive officer and certain of his affiliated entities, and FV Investment Holdings (together with Mr. Zhang and his affiliated entities, the "Buyer Group" , to acquire all of the outstanding shares of iKang not already owned by the Buyer Group in a going private transaction (the "Proposal" . In addition, the Company has retained Wilson Sonsini Goodrich & Rosati, P.C. as its legal counsel in connection with the potential going private transaction contemplated by the Proposal.
JPM: 67.49 (+0.28), KANG: 18.22 (unch)
iKang Schedules 2015 Unaudited Second Quarter Earnings Release on November 30, 2015
GlobeNewswire - Tue Oct 20, 6:00AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company" (Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that it will release its unaudited financial results for the second quarter ended September 30, 2015 on November 30, 2015 after the US market closes.
KANG: 18.22 (unch)
iKang Announces Changes to the Board of Directors
GlobeNewswire - Thu Oct 15, 7:47AM CDT
Board of Directors of iKang Healthcare Group, Inc. ("iKang" or the "Company" (NASDAQ:KANG), announces the resignation of Mr. David Ying Zhang as an independent director and a member of the Compensation Committee of the Board.
KANG: 18.22 (unch)
iKang Announces Unaudited Financial Results for the First Quarter Ended June 30, 2016
GlobeNewswire - Wed Aug 31, 4:00PM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"
(Nasdaq:KANG), the largest provider in China's fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in calendar year 2014, today announced its unaudited financial results for the first quarter ended June 30, 2016. KANG: 18.22 (unch)
iKang Schedules 2016 Unaudited First Quarter Earnings Release on August 31, 2016
GlobeNewswire - Mon Aug 22, 6:00AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"
(Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that it will release its unaudited financial results for the first quarter ended June 30, 2016 on August 31, 2016 after the US market closes. KANG: 18.22 (unch)
iKang Filed 2015 Annual Report on Form 20-F
GlobeNewswire - Mon Aug 01, 6:45AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"
(Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that it filed its annual report on Form 20-F for the fiscal year ended March 31, 2016 with the U.S. Securities and Exchange Commission (the "SEC" on July 29, 2016. The annual report on Form 20-F, which contains the Company's audited financial statements, can be accessed on the SEC's website at http://www.sec.gov as well as via the Company's investor relations website at http://ir.ikang.com. Hard copies of the annual report are available, free of charge, to shareholders upon request. KANG: 18.22 (unch)
iKang Announces Further Update on Potential "Going Private" Transaction
GlobeNewswire - Thu Jun 09, 8:25AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"
(Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced a further update on the potential going private transaction proposed, respectively, by certain buyer groups, including (i) Mr. Ligang Zhang ("Mr. Zhang" , Founder, Chairman and Chief Executive Officer of iKang, and certain of Mr. Zhang's affiliated entities, and FV Investment Holdings (together with certain other investors, the "Founder Buyer Group" , (ii) Meinian Onehealth Healthcare Group Co. (formerly known as Jiangsu Sanyou Group Co., Ltd.) ("Meinian" , Cathay Capital Private Equity SAS ("Cathay" , Shenzhen Ping An Decheng Investment Co., Ltd. ("Ping An" , Taiping Guofa (Suzhou) Capital Management Co., Ltd. ("Taiping" , Sequoia China Investment Management LLP ("Sequoia" and Huatai Ruilian Fund Management Co., Ltd. ("Huatai Ruilian," and together with Meinian, Cathay, Ping An, Taiping, Sequoia and certain other investors, the "Meinian Buyer Group" and (iii) Yunfeng Capital. KANG: 18.22 (unch)
iKang Announces Receipt of Competing Non-Binding "Going Private" Proposal
GlobeNewswire - Mon Jun 06, 8:46AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"
(Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that its board of directors (the "Board" received a preliminary non-binding proposal letter, dated June 6, 2016, from Yunfeng Capital, proposing a going-private transaction in which Yunfeng Capital would acquire all of the outstanding Class A common shares ("Class A Shares" , Class C common shares ("Class C Shares," and together with Class A Shares, the "Shares" and American depositary shares ("ADSs," each representing 1/2 of a Class A Share) of the Company in an all-cash transaction for US$20.00 to US$25.00 per ADS or US$40.00 to US$50.00 per Share (the "Yunfeng Capital Proposal" . KANG: 18.22 (unch)
Why These Stocks are Under the Investor Community's Microscope? - Bruker, Quintiles Transnational Holdings, iKang Healthcare Group, and TrovaGene
PR Newswire - Wed Jun 01, 7:20AM CDT
In today's pre-market research, ActiveWallSt.com has selected the following Medical Laboratories and Research stocks for your evaluation: Bruker Corp. (NASDAQ: BRKR), Quintiles Transnational Holdings Inc. (NYSE: Q), iKang Healthcare Group Inc. (NASDAQ: KANG), and TrovaGene Inc. (NASDAQ: TROV). Access these equities free technical alerts at:
Q: 76.96 (-0.46), TROV: 4.96 (unch), KANG: 18.22 (unch), BRKR: 22.38 (-0.06)
iKang Sues Meinian Onehealth Healthcare Over IP Infringement
GlobeNewswire - Tue May 24, 8:50AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"
(Nasdaq:KANG), China's largest private preventive healthcare services provider, reported that, on April 28, 2016, the Company filed a complaint (the "Copyright Claim" with the Shanghai Intellectual Property Court against Shanghai Mei Dong Software Development Co., Ltd. ("Shanghai Mei Dong" , WANG Haifeng, Deputy General Manager of Shanghai Mei Dong, Meinian Onehealth Healthcare (Group) Co., Ltd. ("Meinian Onehealth" , and Shanghai Sheng Jia Clinic Co., Ltd. ("Sheng Jia" as they have jointly infringed the Company's copyright of medical examination software systems (the "Infringed Softwares" . The Company has requested Meinian Onehealth and Sheng Jia to delete and stop using the relevant softwares (the "Infringing Softwares" , mitigate the impacts, apologize publicly for their violations, and repay the financial damages they have caused in the amount of RMB 53 million. The Shanghai Intellectual Property Court has accepted the Company's complaint (Case number: (2016) Hu73 Min Chu 339-342). KANG: 18.22 (unch)
iKang Announces Acquisition of Two Medical Centers in Beijing
GlobeNewswire - Fri May 20, 6:00AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"
(Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that it has completed the acquisition of 100% equity interest in Beijing Bohui Clinic Co. Ltd. ("Beijing Bohui" and Beijing Zhongpu Bohui Clinic Co. Ltd. ("Zhongpu Bohui" . Beijing Bohui has now officially opened after its relocation, acquiring all necessary licenses including the Medical Institutions Practice License and Business License, and Zhongpu Bohui is currently in the middle of evaluating a new location for its business. KANG: 18.22 (unch)
Expanded Meinian Consortium Reiterates Its Commitment to Acquiring iKang by Further Improving Offer
PR Newswire - Wed Jan 06, 10:48AM CST
Jiangsu Sanyou Group Co Ltd (SZSE: 002044) today announces that it has updated its business license to change the company name to Meinian Onehealth Healthcare Holding Co., Ltd and that the consortium of which it is a member ("the Consortium" or "We"
has submitted a further revised and improved proposal (the "Improved Proposal" to acquire iKang Healthcare Group, Inc. (NASDAQ: KANG, "iKang" . The Improved Proposal was submitted to iKang's Special Committee of the Board of Directors (the "Special Committee" and details the transaction structure as well as the Consortium's ability to swiftly complete the transaction. At the same time, the Consortium admitted three new members, Shanghai YuanXing YinShi Equity Investment Limited Partnership (GGV Capital), Shanghai Sailing Capital Management Co., Ltd., and Haitong Auspicate Capital Management Co., Ltd. KANG: 18.22 (unch)
iKang Announces Acquisition of Shaanxi INLUNG Health Management
GlobeNewswire - Tue Dec 22, 8:03AM CST
iKang Healthcare Group, Inc. ("iKang" or the "Company"
(Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that it has acquired 70% equity interest of Xi'an iKang Health Management, which has 100% ownership in three medical centers under the brand name of Xi'an INLUNG, namely Xi'an Lianhu INLUNG Medical Center, Xi'an Weiyang INLUNG Medical Center and Xi'an Yanta INLUNG Medical Center. KANG: 18.22 (unch)
Meinian Consortium Announces Improved Proposal for iKang
PR Newswire - Mon Dec 14, 12:24PM CST
Jiangsu Sanyou Group Co Ltd (SZSE: 002044, "Jiangsu Sanyou", also known as Meinian Onehealth Healthcare (Group) Co., Ltd) today announces that the consortium of which it is a member ("the Consortium" or "We"
has submitted a revised and improved proposal (the "Improved Proposal" to acquire iKang Healthcare Group, Inc. (NASDAQ: KANG, "iKang" . The Improved Proposal was submitted to the Special Committee of the Board of Directors (the "Special Committee" and the Consortium wishes to express that it remains committed to its objective of acquiring iKang. KANG: 18.22 (unch)
Meinian Responds to iKang's "Poison Pill" Rights Plan
PR Newswire - Thu Dec 03, 12:26PM CST
Jiangsu Sanyou Group Co Ltd (SZSE: 002044, "Jiangsu Sanyou", also known as Meinian Onehealth Healthcare (Group) Co., Ltd, "Meinian"
on behalf of the consortium of which it is a member ("the Consortium" acknowledges iKang Healthcare Group, Inc.'s (NASDAQ: KANG, "iKang" announcement of a Rights Agreement (the "Rights Plan", commonly known as a "poison pill" . KANG: 18.22 (unch)
iKang Healthcare Group, Inc. Adopts Rights Agreement
GlobeNewswire - Wed Dec 02, 8:15AM CST
The Board of Directors of iKang Healthcare Group, Inc. (the "Company"
today adopted a Rights Agreement and authorized the issuance of one Right for each outstanding Class A Common Share and Class C Common Share (the "Rights Plan" . After careful consideration, the Board of Directors of the Company (the "Board" deemed it appropriate and prudent to adopt the Rights Plan at this time in order to ensure that all shareholders of the Company receive fair and equal treatment in the event that an unsolicited attempt is made to acquire the Company outside of the process led by the special committee of independent directors of the Company (the "Special Committee" , which was formed to consider the possibility of a "going private" transaction involving the Company. KANG: 18.22 (unch)
Company News for December 01, 2015
Zacks Equity Research - Zacks Investment Research - Tue Dec 01, 9:10AM CST
Companies in the News are: TGT,KANG,OHGI,SPCB
KANG: 18.22 (unch), TGT: 70.81 (+0.23), SPCB: 3.40 (+0.10), OHGI: 0.70 (-0.02)
iKang Announces Unaudited Financial Results for Fiscal Second Quarter Ended September 30, 2015
GlobeNewswire - Mon Nov 30, 3:00PM CST
iKang Healthcare Group, Inc. ("iKang" or the "Company"
(Nasdaq:KANG), the largest provider in China's fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in calendar year 2014, today announced its unaudited financial results for the fiscal second quarter ended September 30, 2015. KANG: 18.22 (unch)
Consortium Submits Preliminary Non-binding Proposal to Acquire Nasdaq-listed iKang
PR Newswire - Sun Nov 29, 3:15AM CST
Jiangsu Sanyou Group Co Ltd (SZSE: 002044, "Jiangsu Sanyou", also known as Meinian Onehealth Healthcare (Group) Co., Ltd.), announces today that it is a member of a consortium which has submitted a preliminary non-binding proposal (the "Proposal"
to acquire iKang Healthcare Group, Inc. ("iKang" (NASDAQ: KANG). KANG: 18.22 (unch)
iKang Special Committee Engages Financial Advisor and Legal Counsel
GlobeNewswire - Tue Nov 10, 6:00AM CST
iKang Healthcare Group, Inc. ("iKang" or the "Company"
(Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that the special committee (the "Special Committee" of the Company's board of directors (the "Board" has retained J.P. Morgan Securities (Asia Pacific) Limited as its financial advisor, Simpson Thacher & Bartlett as its international legal counsel, and Walkers as its Cayman Islands legal counsel in connection with its review and evaluation of the preliminary non-binding proposal letter dated August 31, 2015 from Mr. Ligang Zhang ("Mr. Zhang" , the Company's founder, chairman and chief executive officer and certain of his affiliated entities, and FV Investment Holdings (together with Mr. Zhang and his affiliated entities, the "Buyer Group" , to acquire all of the outstanding shares of iKang not already owned by the Buyer Group in a going private transaction (the "Proposal" . In addition, the Company has retained Wilson Sonsini Goodrich & Rosati, P.C. as its legal counsel in connection with the potential going private transaction contemplated by the Proposal. JPM: 67.49 (+0.28), KANG: 18.22 (unch)
iKang Schedules 2015 Unaudited Second Quarter Earnings Release on November 30, 2015
GlobeNewswire - Tue Oct 20, 6:00AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"
(Nasdaq:KANG), China's largest private preventive healthcare services provider, today announced that it will release its unaudited financial results for the second quarter ended September 30, 2015 on November 30, 2015 after the US market closes. KANG: 18.22 (unch)
iKang Announces Changes to the Board of Directors
GlobeNewswire - Thu Oct 15, 7:47AM CDT
Board of Directors of iKang Healthcare Group, Inc. ("iKang" or the "Company"
(NASDAQ:KANG), announces the resignation of Mr. David Ying Zhang as an independent director and a member of the Compensation Committee of the Board. KANG: 18.22 (unch)
(0)
(0)Scroll down for more posts ▼